|
Market Closed -
Toronto S.E.
11:39:14 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 3.440 CAD | 0.00% |
|
-2.27% | +27.41% |
| 07-28 | BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | BioRem Q2 Net Earnings Rise to C$0.11 Per Share | MT |
Company Valuation: BioRem Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Market Cap 1 | 49.17 | 43.52 | 55.79 | - |
| Change | - | -11.49% | 28.2% | - |
| Enterprise Value (EV) | 49.17 | 43.52 | 55.79 | 55.79 |
| Change | - | -11.49% | 28.2% | 0% |
| P/E | 19.1x | 10.4x | 10.1x | 8x |
| PBR | - | - | - | - |
| PEG | - | 0.2x | 0.3x | 0.3x |
| Capitalization / Revenue | - | - | 1.07x | 0.95x |
| EV / Revenue | - | - | 1.07x | 0.95x |
| EV / EBITDA | - | - | 6.06x | 5.07x |
| EV / EBIT | - | - | - | - |
| EV / FCF | - | - | 9x | 7.25x |
| FCF Yield | - | - | 11.1% | 13.8% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | 0.16 | 0.26 | 0.34 | 0.43 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | - | 52.1 | 58.9 |
| EBITDA 1 | - | - | 9.2 | 11 |
| EBIT | - | - | - | - |
| Net income | 3.044 | 4.817 | - | - |
| Net Debt | - | - | - | - |
| Reference price 2 | 3.050 | 2.700 | 3.440 | 3.440 |
| Nbr of stocks (in thousands) | 16,120 | 16,117 | 16,217 | - |
| Announcement Date | 4/16/25 | 4/20/26 | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.12x | - | - | - | 40.03M | ||
| 22.15x | 2.86x | 15.31x | 1.39% | 10.01B | ||
| 207.22x | 3.26x | 20.45x | - | 4.07B | ||
| 17.88x | 2.65x | 12.49x | 1.92% | 3.49B | ||
| 27.5x | - | - | - | 1.29B | ||
| Average | 56.97x | 2.92x | 16.08x | 1.66% | 3.78B | |
| Weighted average by Cap. | 61.53x | 2.91x | 15.94x | 1.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRM Stock
- Valuation BioRem Inc.
Select your edition
All financial news and data tailored to specific country editions
















